直肠癌观察等待策略是否存在肿瘤大小限制?两项前瞻性研究的汇总结果
cCR率为低危39.0%、中危16.8%、高危5.4%;肿瘤体积(或长度与环周受累)及cN状态是cCR的显著预测因素。环周肿瘤或长度≥7 cm者cCR率仅2.7%,>120 cm³者无一例达cCR。
要点
- 低危cT1-2N0的cCR率为39.0%,中危16.8%,高危5.4%。
- 环周肿瘤或长度≥7 cm者cCR率仅2.7%,持续cCR 1.6%。
- 肿瘤>120 cm³的27例患者无一例达到cCR。
核心结论
- 环周肿瘤或肿瘤长度≥7 cm的患者考虑观察等待策略存疑。
- 肿瘤体积(或长度与环周受累)及cN状态是cCR的显著预测因素。
研究设计与样本
- 第一项为单中心研究,纳入老年小肿瘤患者;第二项为多中心研究,纳入接受标准术前放疗的所有患者。
主要发现
- cCR率低危(cT1-2N0)39.0%,中危(cT3且MRF-或cT2N+)16.8%,高危(cT4或MRF+)5.4%。
- 环周肿瘤或长度≥7 cm者(n=184)cCR率2.7%,持续cCR 1.6%,cCR诊断敏感性23.1%。
- 肿瘤>120 cm³的27例患者无一例达到cCR。
- 短程放疗开始至首次肿瘤反应评估中位间隔10.2周,化放疗为13.2周。
关键数值与推荐
- 短程放疗 alone、短程放疗联合巩固化疗、化放疗分别占40.6%、40.2%、19.2%。
- 多因素分析中肿瘤体积(或肿瘤长度与环周受累)及cN状态为cCR显著预测因素。
临床怎么用
- 评估观察等待策略前应关注肿瘤体积、长度、环周受累及cN状态。
- 对环周肿瘤或长度≥7 cm者应谨慎考虑观察等待策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frequency and predictive factors for a clinical complete response (cCR) in unselected patients are unclear. MATERIAL AND METHODS: Two prospective observational studies were designed and pooled to explore predictive factors for cCR. Both studies evaluated the watch-and-wait strategy in consecutive patients; the first single-institutional study in elderly with a small tumour, the second multi-institutional study in all the patients receiving standard of care preoperative radiotherapy. RESULTS: Four hundred and ninety patients were analysed. Short-course radiotherapy alone, or with consolidation chemotherapy or chemoradiation was given to 40.6%, 40.2% and 19.2% of the patients, respectively. The median interval from the radiation start to the first tumour response assessment was 10.2 weeks for short-course radiation and 13.2 weeks for chemoradiation. Seventy-three patients had cCR and 71 underwent w&w with the median follow-up of 24 months. The regrowth rate was 26.8%. cCR rate was 39.0% for low-risk cancer (cT1-2N0), 16.8% for intermediate-risk (cT3 with unthreatened mesorectal fascia [MRF-] or cT2N+) and 5.4% for high-risk (cT4 or MRF+). In the multivariable analysis, tumour volume (or tumour length and circumferential extent) and cN status were significant predictors for cCR. In circular cancers or with a length ≥7 cm (n = 184), cCR rate was only 2.7%, sustained cCR 1.6% and the sensitivity of cCR diagnosis 23.1%. None of 27 patients with a tumour larger than 120 cm3 achieved cCR. CONCLUSIONS: Considering watch-and-wait strategy is questionable in patients with circular tumours or with tumour length ≥7 cm.
引用
- Jankowski M, Pietrzak L, Rupiński M, et al. Watch-and-wait strategy in rectal cancer: Is there a tumour size limit? Results from two pooled prospective studies. Radiother Oncol. 2021. PMID: 34023328. doi:10.1016/j.radonc.2021.05.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。